Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program.

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 25 July 2016
Author/s

author: Thierry André  David Tougeron  Christelle de la Fouchardière  Jean-Marc Phelip 

Publication date July 25, 2016
Language English
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item